CollPlant Biotechnologies (CLGN) Gross Profit (2017 - 2026)
CollPlant Biotechnologies' (CLGN) quarterly Gross Profit came in at -$243000.0 in Q1 2026, down 113.02% YoY from $1.9 million in Q1 2025, and down 84.09% on a QoQ basis from -$132000.0 in Q4 2025.
CollPlant Biotechnologies (CLGN) Gross Profit (2017 - 2026) Analysis & Trends
CollPlant Biotechnologies (CLGN) has 10 years of Gross Profit data on file, last reported at -$243000.0 in Q1 2026.
- Quarterly Gross Profit fell 113.02% year-over-year to -$243000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$7.0 billion (down 581542.44% YoY) and the FY2025 annual result came in at $1.5 million, up 238.38% from the prior year.
- Gross Profit declined to -$243000.0 in Q1 2026, from -$132000.0 in the prior quarter.
- In the past five years, Gross Profit ranged from a high of $9.6 million in Q2 2023 to a low of -$7.0 billion in Q2 2025.
- A 5-year average of -$411.2 million and a median of -$155000.0 in 2022 frame the typical range for Gross Profit.
- Annual changes were most pronounced in 2023 — Gross Profit soared 41504.35% — and 2025, when it tumbled 2438924.39%.
- Tracing CLGN's Gross Profit over 5 years: stood at -$4000.0 in 2022, then slumped by 11750.0% to -$474000.0 in 2023, then soared by 77.22% to -$108000.0 in 2024, then decreased by 22.22% to -$132000.0 in 2025, then tumbled by 84.09% to -$243000.0 in 2026.
- The last three Gross Profit figures came in at -$243000.0 (Q1 2026), -$132000.0 (Q4 2025), and -$192000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | CollPlant Biotechnologies | 4.26 Mn | 4.26 Mn | -243,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 30, 2026 | -243,000.00 |
| Mar 30, 2026 | -243,000.00 |
| Dec 31, 2025 | -132,000.00 |
| Dec 31, 2025 | -132,000.00 |
| Sep 30, 2025 | -192,000.00 |
| Sep 30, 2025 | -192,000.00 |
| Jun 30, 2025 | -7.00 Bn |
| Jun 30, 2025 | -7.00 Bn |
| Mar 30, 2025 | 1.87 Mn |
| Mar 30, 2025 | 1.87 Mn |
| Dec 31, 2024 | -108,000.00 |
| Dec 31, 2024 | -108,000.00 |
| Sep 30, 2024 | -268,000.00 |
| Sep 30, 2024 | -268,000.00 |
| Jun 30, 2024 | -287,000.00 |
| Jun 30, 2024 | -287,000.00 |
| Mar 31, 2024 | -447,000.00 |
| Mar 31, 2024 | -447,000.00 |
| Dec 31, 2023 | -474,000.00 |
| Dec 31, 2023 | -474,000.00 |